Lutembacher syndrome, a combination of congenital atrial septal defect (ASD) complicated by acquired mitral stenosis,1 has been traditionally treated by open-heart surgery.2 With the introduction of transcatheter closure of ASD3 and percutaneous balloon mitral valvuloplasty,4 then Lutembacher syndrome can be treated percutaneously. Percutaneous management of Lutembacher syndrome can obviate the morbidity and mortality associated with cardiac surgery, the psychological trauma of a thoracotomy scar and the possibility of repeat thoracotomy for mitral restenosis. So the technique may be ideal for treatment of Lutembacher syndrome.